Medicare has covered treatment for anyone with end-stage renal disease since 1972. The coverage is very expensive and the program has struggled since for 40 years to contain costs without compromising quality. In a new paper that chronicles that history, the authors argue that Medicare’s latest attempt — bundled payments and pay-for-performance — could become a broader model for the program if it succeeds.